FDA Proposes Rule to Modernize Drug Manufacturing Registration
The FDA released a proposed rule to modernize drug manufacturing registration. The rule targets distributed manufacturing establishments utilizing a 'hub-and-spoke' model.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day